Martorano L, Erwin EA. Aeroallergen Exposure and Spread in the Modern Era. J Allergy Clin Immunol Pract. 2018;6:1835–42.

PubMed  Google Scholar 

Akar-Ghibril N, Casale T, Custovic A, et al. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020;8:429–40.

PubMed  PubMed Central  Google Scholar 

Farrokhi S, Gheybi MK, Movahed A, et al. Common aeroallergens in patients with asthma and allergic rhinitis living in southwestern part of Iran: based on skin prick test reactivity. Iran J Allergy Asthma Immunol. 2015;14:133–8.

PubMed  Google Scholar 

Craig TJ. Aeroallergen sensitization in asthma: prevalence and correlation with severity. Allergy Asthma Proc. 2010;31:96–102.

CAS  PubMed  Google Scholar 

Eiringhaus K, Renz H, Matricardi P, et al. Component-Resolved Diagnosis in Allergic Rhinitis and Asthma. J Appl Lab Med. 2019;3:883–98.

CAS  PubMed  Google Scholar 

Peters N, Peters AT. Atopic dermatitis. Allergy Asthma Proc. 2019;40:433–6.

CAS  PubMed  Google Scholar 

Tamagawa-Mineoka R, Katoh N. Atopic Dermatitis: Identification and Management of Complicating Factors. Int J Mol Sci. 2020;21:E2671.

PubMed  Google Scholar 

Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-1258.e23.

PubMed  Google Scholar 

Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol. 2013;132:1132–8.

PubMed  Google Scholar 

Sandhu JK, Wu KK, Bui T-L, et al. Association Between Atopic Dermatitis and Suicidality: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155:178–87.

PubMed  Google Scholar 

David Boothe W, Tarbox JA, Tarbox MB. Atopic Dermatitis: Pathophysiology. Adv Exp Med Biol. 2017;1027:21–37.

CAS  PubMed  Google Scholar 

Silverberg JI, Hanifin J, Simpson EL. Climatic factors are associated with childhood eczema prevalence in US. J Invest Dermatol. 2013;133:1752–9.

CAS  PubMed  PubMed Central  Google Scholar 

•• Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 2015; 136:96–103.e9. The first double-blind placebo-controlled study which confirmed aeroallergens as a direct trigger in atopic dermatitis.

Badorrek P, Dick M, Emmert L, et al. Pollen starch granules in bronchial inflammation. Ann Allergy Asthma Immunol. 2012;109:208-14.

van der Heijden FL, Joost van Neerven RJ, van Katwijk M, et al. Serum-IgE-facilitated allergen presentation in atopic disease. J Immunol. 1993;150:3643–3650.

Maurer D, Ebner C, Reininger B, et al. The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. J Immunol. 1995;154:6285–90.

CAS  PubMed  Google Scholar 

Sharquie IK, Al-Ghouleh A, Fitton P, et al. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells. BMC Immunol. 2013;14:54.

PubMed  PubMed Central  Google Scholar 

Novak N, Bieber T, Kraft S. Immunoglobulin E-bearing antigen-presenting cells in atopic dermatitis. Curr Allergy Asthma Rep. 2004;4:263–9.

PubMed  Google Scholar 

Cooper D, Hales J, Camp R. IgE-Dependent Activation of T cells by Allergen in Atopic Dermatitis: Pathophysiologic Relevance. J Investig Dermatol. 2004;123:1086–91.

CAS  PubMed  Google Scholar 

Campana R, Dzoro S, Mittermann I, et al. Molecular aspects of allergens in atopic dermatitis. Curr Opin Allergy Clin Immunol. 2017;17:269–77.

CAS  PubMed  PubMed Central  Google Scholar 

Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396:345–60.

CAS  PubMed  Google Scholar 

Oetjen LK, Mack MR, Feng J, et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell. 2017;171:217-228.e13.

CAS  PubMed  PubMed Central  Google Scholar 

Gandhi NA, Bennett BL, Graham NMH, et al. Targeting key proximal drivers of type 2 inflammation in disease. Nat Rev Drug Discov. 2016;15:35–50.

CAS  PubMed  Google Scholar 

Werfel T, Breuer K, Ruéff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy. 2006;61:202–5.

CAS  PubMed  Google Scholar 

Hijnen D, Knol EF, Gent YY, et al. CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ, IL-13, IL-17 and IL-22. J Invest Dermatol 2013;133. https://doi.org/10.1038/jid.2012.456.

Trautmann A, Akdis M, Kleemann D, et al. T cell–mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106:25–35.

CAS  PubMed  PubMed Central  Google Scholar 

De Benedetto A, Rafaels NM, McGirt LY, et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol. 2011;127(773–786):e1-7.

Google Scholar 

Yoshida K, Kubo A, Fujita H, et al. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol. 2014;134:856–64.

PubMed  Google Scholar 

Brandner JM, Zorn-Kruppa M, Yoshida T, et al. Epidermal tight junctions in health and disease. Tissue Barriers. 2015;3: e974451.

Lee CH, Chuang HY, Hong CH, et al. Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis. Br J Dermatol. 2011;164:483–9.

CAS  PubMed  PubMed Central  Google Scholar 

Endo K, Hizawa T, Fukuzumi T, et al. [Keeping dogs indoor aggravates infantile atopic dermatitis]. Arerugi. 1999;48: 1309–1315.

Jaworek AK, Szafraniec K, Jaworek M, et al. Cat Allergy as a Source Intensification of Atopic Dermatitis in Adult Patients. Adv Exp Med Biol. 2020;1251:39–47.

CAS  PubMed  Google Scholar 

Pónyai G, Hidvégi B, Németh I, et al. Contact and aeroallergens in adulthood atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:1346–55.

PubMed  Google Scholar 

Kutlu A, Karabacak E, Aydin E, et al. Relationship between skin prick and atopic patch test reactivity to aeroallergens and disease severity in children with atopic dermatitis. Allergol Immunopathol. 2013;41:369–73.

CAS  Google Scholar 

Tan BB, Weald D, Strickland I, et al. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet. 1996;347:15–8.

CAS  PubMed  Google Scholar 

Oosting A-J, de Bruin-Weller MS, Terreehorst I, et al. Effect of mattress encasings on atopic dermatitis outcome measures in a double-blind, placebo-controlled study: the Dutch mite avoidance study. J Allergy Clin Immunol. 2002;110:500–6.

PubMed  Google Scholar 

Kim J, Lee S, Woo S, et al. The Indoor Level of House Dust Mite Allergen Is Associated with Severity of Atopic Dermatitis in Children. J Korean Med Sci. 2013;28:74–9.

PubMed  PubMed Central  Google Scholar 

Sanda T, Yasue T, Oohashi M, et al. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;89:653–7.

CAS  PubMed  Google Scholar 

Colloff MJ, Lever RS, McSharry C. A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations. Br J Dermatol. 1989;121:199–208.

CAS  PubMed  Google Scholar 

Holm L, Bengtsson A, van Hage-Hamsten M, et al. Effectiveness of occlusive bedding in the treatment of atopic dermatitis–a placebo-controlled trial of 12 months’ duration. Allergy. 2001;56:152–8.

CAS  PubMed  Google Scholar 

Katoh N, Hirano S, Suehiro M, et al. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Clin Exp Immunol. 2000;121:187–92.

CAS  PubMed  PubMed Central  Google Scholar 

Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925-931.e4.

CAS  PubMed  Google Scholar 

Pajno GB, Caminiti L, Vita D, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol. 2007;120:164–70.

CAS  PubMed  Google Scholar 

•• Langer SS, Cardili RN, Melo JML, et al. Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice. Epub ahead of print 10 November 2021. https://doi.org/10.1016/j.jaip.2021.10.060. A double-blind placebo-controlled trial showing the efficacy of house dust mite sublingual immunotherapy in atopic dermatitis.

Patella V, Florio G, Palmieri M, et al. Atopic dermatitis severity during exposure to air pollutants and weather changes with an Artificial Neural Network (ANN) analysis. Pediatr Allergy Immunol. 2020;31:938–45.

PubMed  Google Scholar 

•• Wassmann-Otto A, Heratizadeh A, Wichmann K, et al. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy 2018; 73: 2046–2054. Interesting study showing the trigger of atopic dermatitis by pollen-related foods.

Reekers R, Busche M, Wittmann M, et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104:466–72.

CAS  PubMed  Google Scholar 

Heratizadeh A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Curr Allergy Asthma Rep. 2011;11:284–91.

CAS  PubMed  Google Scholar 

Anderson LB, Dreyfuss EM, Logan J, et al. Melon and banana sensitivity coincident with ragweed pollinosis. J Allergy. 1970;45:310–9.

PubMed  Google Scholar 

Antia C, Baquerizo K, Korman A, et al. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018;79:599–614.

PubMed  Google Scholar 

Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73:1393–414.

CAS  PubMed  Google Scholar 

Hon KL, Leung AKC, Ng WGG, et al. Chronic Urticaria: An Overview of Treatment and Recent Patents. Recent Pat Inflamm Allergy Drug Discov. 2019;13:27–37.

CAS  PubMed  PubMed Central  Google Scholar 

Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy. 2005;60:1073–8.

CAS  PubMed  Google Scholar 

Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154:294–